Back to Organizations
Vibe Bio
Vibe Bio provides VibeOne, an AI-powered decision infrastructure platform for biopharma business development, helping BD&L teams speed up asset diligence, identify more assets, and reduce SME workload. Vibe Bio also invests in founders working on cures for rare and overlooked diseases.
Distributed
Description
Vibe Bio builds VibeOne, an AI decision infrastructure platform for biopharma business development, enabling faster and better drug decisions through AI-powered insights, asset triage, and due diligence support. The platform helps BD&L teams identify the full landscape of drug assets to target, track changes, and prioritize opportunities with greater speed and precision, reporting outcomes such as 8x faster asset diligence, 75% reduction in SME workload, and 50% more assets identified. In addition to its software platform, Vibe Bio operates a venture fund that invests in founders committed to finding cures for rare and overlooked diseases, serving biopharma companies and BD&L executives as its typical clients.Grant Funding
VC Funding
None
2022
$0
$12M